The Biological Role of Cervical Cancer Suppressor 3 (CCS-3): Literature Review
- Authors
-
-
Luigi Cristiano
R&D Division, Prestige, Loro Ciuffenna (AR), Italy
-
- Keywords:
- Cancer, EEFs, Cervical cancer suppressor 3 (CCS-3), EEF1A, Apoptosis.
- Abstract
-
CCS-3 is one of the isoforms of eEF1A1, the key protein of the translation elongation step. Discovered in 2006, it has been the subject of some studies on human cervical cancer cell lines and cervical cancer samples. These studies brought to identify its probable role as a transcriptional co-repressor but other functions are currently unknown. It has also been shown that it is able to inhibit cell growth and induce apoptosis in the tumor cells that downregulate it. Further studies could highlight its functions and its possible usefulness as a tumor marker. This review aims to brief the research about CCS-3 that has been carried out so far.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Keishla M. García, Karla M. Flores, Adriana Falcón, Charlynne De Jesus, Loida Del Rio, Laura C. Rivera, Michelle Marquez, Santos Ortiz, Gretchen Sandoval, Alejandro Ruiz, Fabiola Rodriguez, Frances Gonzalez, Kenneth Cintron, Miguel J. Berdiel, Jorge Duconge, Maricelly Santiago, Ines Alfaro, Michael J. Gonzalez, Perioperative Effects of Surgery, Anesthesia and Analgesics Associated with Cancer Progression: A Review , Journal of Cancer Research Updates: Vol. 7 No. 1 (2018)
- Indravesh Indravesh, Arvind Kumar Yadav, Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer , Journal of Cancer Research Updates: Vol. 15 No. 3 (2026)
- Joseph V. Pergolizzi, Gianpietro Zampogna, Robert Taylor, Marixa Guerrero, Juan Quillermo Santacruz, Robert B. Raffa, A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients , Journal of Cancer Research Updates: Vol. 5 No. 1 (2016)
- Michael T. Hardin, Amy S. Harrison, Virginia L. Lockamy, Jun Li, Cheng Peng, Peter Potrebko, Yan Yu, Laura Doyle, Junsheng Cao, Evaluation of the Type and Frequency of Errors Discovered During Routine Secondary Patient Chart Review , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
- Fatma F. Abdel Hamid, Mahmoud K. Singer, Mahmoud N. El-Rouby, Mahmoud M. Said, Reda H. Tabashy, Motawa E. El-Houseini, HepG2 Attenuation Induced by RNase A Modulates Gene Profiling and Immunophenotypic Characterization of Some Immune Cells Operating in Cancer Vaccine , Journal of Cancer Research Updates: Vol. 7 No. 1 (2018)
- Muqaddam Shohzodaeva, Uldoshev Ravshan Zohidovich, Rachel Kansiime, Joyeeta Talukdar, From Hidden Burden to Visible Care: Integrating Psycho-Oncology into Breast Cancer Control in Tajikistan through Indian and African Models , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Sisir Nandi, Manish C. Bagchi, EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- F. Gloria-Bottini, M. Nicotra, C. Spina, P.L. Benedetti-Panici, P. Saccucci, A. Neri, A. Magrini, E. Bottini, P53 Codon 72 and Endometrium Cancer , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Cord Naujokata, Stefan Laufer, Targeting Cancer Stem Cells with Defined Compounds and Drugs , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- Dimple Sethi Chopra , Challenges in Development of Nanomedicine for Treatment of Cancer , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
You may also start an advanced similarity search for this article.